LeadMuta

LeadMuta Biotechnology, Inc. is dedicated to leveraging AI-driven small molecule lead discovery and translation to build a novel drug development pipeline based on artificial intelligence, computational chemistry, medicinal chemistry, and other disciplines. It is an innovative entrepreneurial team primarily composed of high-level returnee talents from AstraZeneca, Roche, Carnegie Mellon, MIT, Scripps, and other prestigious institutions abroad. The founding team has over 30 years of experience in drug research and development as well as working at world-class pharmaceutical companies, with expertise in small molecule compound research and extensive experience in areas such as anti-tumor, antiviral, and central nervous system therapies.